MRKR

$1.36

Pre-MarketAs of Mar 17, 8:00 PM UTC

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications.

Intraday

Custom Range:
to
No data available for this range. Intraday data may be limited by the exchange.

Recent News

Zacks
Mar 5, 2026

Profound Medical (PROF) Reports Q4 Loss, Misses Revenue Estimates

Profound Medical (PROF) delivered earnings and revenue surprises of 0.00% and -21.87%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Simply Wall St.
Feb 19, 2026

Exploring 3 High Growth Tech Stocks In The US Market

As the U.S. stock market kicks off February with a robust performance, highlighted by significant gains in major indices such as the Dow Jones Industrial Average and S&P 500, investors are closely watching the tech sector for potential high-growth opportunities. In this dynamic environment, identifying promising tech stocks involves considering factors like innovation, market demand, and adaptability to current economic conditions.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Feb 18, 2026

High Growth Tech Stocks In The US Market February 2026

As February 2026 begins, the U.S. stock market is experiencing a robust start with major indices like the Dow Jones Industrial Average and S&P 500 showing significant gains, reflecting positive investor sentiment despite recent economic uncertainties such as delayed jobs data due to a partial government shutdown. In this dynamic environment, identifying high-growth tech stocks involves looking for companies that demonstrate strong innovation capabilities and resilience in adapting to evolving...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Feb 10, 2026

High Growth Tech Stocks In US With Promising Potential

As February begins, major U.S. stock indexes have surged, with the Dow Jones Industrial Average rising by 515 points and the S&P 500 nearing a record high, reflecting positive market sentiment despite recent economic uncertainties such as delayed jobs data due to a government shutdown. In this environment of heightened optimism and volatility, identifying high growth tech stocks with promising potential requires focusing on companies that demonstrate strong innovation capabilities and...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Feb 5, 2026

High Growth Tech Stocks to Watch in US February 2026

As February 2026 begins, the U.S. stock market has shown strength with major indices like the Dow Jones and S&P 500 posting significant gains, buoyed by positive economic indicators such as an unexpected expansion in manufacturing activity. In this environment of heightened market optimism, identifying high-growth tech stocks involves focusing on companies that demonstrate robust innovation and adaptability to capitalize on emerging trends and technological advancements.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.